Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

645 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
Nakai K, Mineishi S, Kami M, Saito T, Hori A, Kojima R, Imataki O, Hamaki T, Yoshihara S, Ohnishi M, Kim SW, Ando T, Fumitoh A, Kanda Y, Makimoto A, Tanosaki R, Kanai S, Heike Y, Ohnishi T, Kawano Y, Wakasugi H, Takaue Y. Nakai K, et al. Among authors: yoshihara s. Transplantation. 2003 Jun 27;75(12):2135-43. doi: 10.1097/01.TP.0000066453.32263.F7. Transplantation. 2003. PMID: 12829926
High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma.
Tanimoto TE, Kusumi E, Hamaki T, Yuji K, Ueyama J, Miyakoshi S, Morinaga S, Kami M, Kanda Y, Ando T, Yoshihara S, Masuo S, Kim SW, Nakai K, Tobinai K, Tanosaki R, Mineishi S, Takaue Y, Muto Y. Tanimoto TE, et al. Among authors: yoshihara s. Bone Marrow Transplant. 2003 Jul;32(2):131-7. doi: 10.1038/sj.bmt.1704118. Bone Marrow Transplant. 2003. PMID: 12838276 Clinical Trial.
A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donors.
Komeno Y, Kanda Y, Hamaki T, Mitani K, Iijima K, Ueyama J, Yoshihara S, Yuji K, Kim SW, Ando T, Kami M, Yamamoto E, Hiruma K, Mori S, Hirai H, Sakamaki H; Japan Hematology and Oncology Clinical Study Group. Komeno Y, et al. Among authors: yoshihara s. Biol Blood Marrow Transplant. 2006 Apr;12(4):408-13. doi: 10.1016/j.bbmt.2005.11.007. Biol Blood Marrow Transplant. 2006. PMID: 16545724 Free article. Clinical Trial.
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I. Ogawa H, et al. Among authors: yoshihara s. Biol Blood Marrow Transplant. 2006 Oct;12(10):1073-84. doi: 10.1016/j.bbmt.2006.06.007. Biol Blood Marrow Transplant. 2006. PMID: 17084371 Free article. Clinical Trial.
Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K, Yoshihara S, Taniguchi Y, Kaida K, Inoue T, Okada M, Taniguchi K, Hasei H, Tamaki H, Fujioka T, Kato R, Soma T, Ogawa H. Ikegame K, et al. Among authors: yoshihara s. Exp Hematol. 2011 Aug;39(8):880-90. doi: 10.1016/j.exphem.2011.05.007. Epub 2011 May 27. Exp Hematol. 2011. PMID: 21689724 Free article. Clinical Trial.
645 results